Wells Fargo analyst Gary Mobley maintains Synopsys (NASDAQ:SNPS) with a Overweight and raises the price target from $400 to $415.
Titan Medical Implements Cost-Cutting Measures To Support Strategic Review Process
Titan Medical Inc. (NASDAQ:TMDI, TSX:TMD), a medical technology company focused on single access robotic-assisted surgery (RAS) system, today announced the company will implement certain cost-cutting measures with a view
